drugset / Trial / NCT02054949

Treatment Resistant Epilepsy and N-Acetyl Cysteine

NCT02054949

NaSingle-groupOpen-labelTreatment

Summary

This is a study to find out whether the dietary amino acid supplement, N-acetyl cysteine (NAC) is helpful in reducing the frequency of seizures in children with autism and comorbid epilepsy whose seizures are not responding well to usual medical treatment. The study is also looking to see if this supplement is helpful for immediate and ongoing treatment of symptoms of irritability. Additionally, this study will also look to see if certain substances in the blood that measure a specific type of stress on cells in the body can help tell us how NAC may be helping.

Timeline

Start
2013-04
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 1000 mg Oral